Glucose and Lipoprotein Biomarkers and Breast Cancer Severity Using Data From the Swedish AMORIS Cohort

BMC Cancer - United Kingdom
doi 10.1186/s12885-017-3232-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Thyroid Cancer Risk in the Swedish AMORIS Study: The Role of Inflammatory Biomarkers in Serum

Oncotarget
Oncology
2017English

Serum Inflammatory Markers in Relation to Prostate Cancer Severity and Death in the Swedish AMORIS Study

International Journal of Cancer
Cancer ResearchOncology
2018English

Chronic Inflammation Markers Are Associated With Risk of Pancreatic Cancer in the Swedish AMORIS Cohort Study

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Inorganic Phosphate and the Risk of Cancer in the Swedish AMORIS Study

BMC Cancer
Cancer ResearchOncologyGenetics
2013English

Metabolic Serum Biomarkers for the Prediction of Cancer: A Follow-Up of the Studies Conducted in the Swedish AMORIS Study

ecancermedicalscience
Cancer ResearchOncology
2015English

Folate Intake and Breast Cancer Mortality in a Cohort of Swedish Women

Breast Cancer Research and Treatment
Cancer ResearchOncology
2011English

Serum Biomarkers to Predict Risk of Testicular and Penile Cancer in AMORIS

ecancermedicalscience
Cancer ResearchOncology
2017English

A Prospective Investigation of Oral Contraceptive Use and Breast Cancer Mortality: Findings From the Swedish Women’s Lifestyle and Health Cohort

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Fetal Growth and Subsequent Risk of Breast Cancer: Results From Long Term Follow Up of Swedish Cohort

BMJ
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy